• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Genetic Testing: What Problem Are We Trying to Solve?

作者信息

Hughes Kevin S

机构信息

Kevin S. Hughes, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

出版信息

J Clin Oncol. 2017 Dec 1;35(34):3789-3791. doi: 10.1200/JCO.2017.74.7899. Epub 2017 Aug 18.

DOI:10.1200/JCO.2017.74.7899
PMID:28820645
Abstract
摘要

相似文献

1
Genetic Testing: What Problem Are We Trying to Solve?基因检测：我们试图解决什么问题？
J Clin Oncol. 2017 Dec 1;35(34):3789-3791. doi: 10.1200/JCO.2017.74.7899. Epub 2017 Aug 18.
2
Genetic Testing: Multiple Problems to Solve.基因检测：有待解决的多重问题。
J Clin Oncol. 2018 Feb 10;36(5):518-519. doi: 10.1200/JCO.2017.76.0942. Epub 2018 Jan 2.
3
Reply to E. Ramos et al.对E. 拉莫斯等人的回复
J Clin Oncol. 2018 Feb 10;36(5):520. doi: 10.1200/JCO.2017.76.4092. Epub 2018 Jan 2.
4
Reply to S. Nakamura et al and S. Narod et al.对S. 中村等人及S. 纳罗德等人的回复
J Clin Oncol. 2018 Feb 10;36(5):517-518. doi: 10.1200/JCO.2017.76.4100. Epub 2018 Jan 2.
5
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.对每个上皮性卵巢癌患者进行胚系 BRCA1/2 突变检测的指征：系统评价。
Eur J Cancer. 2016 Jul;61:137-45. doi: 10.1016/j.ejca.2016.03.009. Epub 2016 May 19.
6
BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.非黏液性上皮性卵巢癌中的BRCA1/2种系检测：国际实践的变化及对服务提供的影响
Eur J Hum Genet. 2017 Feb;25(2):167-168. doi: 10.1038/ejhg.2016.138. Epub 2016 Oct 19.
7
Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.欢迎对卵巢癌患者进行BRCA1/BRCA2普遍检测，但需谨慎：女性和工作人员如何看待扩大检测可及性的经历。
J Genet Couns. 2017 Dec;26(6):1280-1291. doi: 10.1007/s10897-017-0108-5. Epub 2017 May 24.
8
A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.一项针对高级别非黏液性上皮性卵巢癌患者的通用基因检测倡议及其对癌症治疗的影响。
Gynecol Oncol. 2017 Aug;146(2):399-404. doi: 10.1016/j.ygyno.2017.05.037. Epub 2017 Jun 10.
9
[A survey of willingness about genetic counseling and tests in patients of epithelial ovarian cancer].[上皮性卵巢癌患者对遗传咨询及检测的意愿调查]
Zhonghua Yi Xue Za Zhi. 2017 Nov 21;97(43):3412-3415. doi: 10.3760/cma.j.issn.0376-2491.2017.43.011.
10
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.卵巢癌患者BRCA基因检测建议的当前观点
Eur J Cancer. 2016 Dec;69:127-134. doi: 10.1016/j.ejca.2016.10.006. Epub 2016 Nov 4.

引用本文的文献

1
Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022-March 2023).检测中的不匹配：对英国和爱尔兰多个专科中心子宫内膜癌错配修复检测及林奇综合征诊断的回顾性分析（2022年3月 - 2023年3月）
BMJ Oncol. 2025 Jun 9;4(1):e000688. doi: 10.1136/bmjonc-2024-000688. eCollection 2025.
2
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.胰腺导管腺癌患者的癌症易感性基因检测：在癌症中心肿瘤诊所的实施情况
JCO Precis Oncol. 2025 Feb;9:e2400494. doi: 10.1200/PO-24-00494. Epub 2025 Feb 12.
3
Differential Receipt of Genetic Services Among Patients With Gynecologic Cancer and Their Relatives: A Review of Challenges to Health Equity.
妇科癌症患者及其亲属在遗传服务方面的差异获得：对健康公平性挑战的综述。
Clin Obstet Gynecol. 2024 Dec 1;67(4):666-671. doi: 10.1097/GRF.0000000000000893. Epub 2024 Sep 27.
4
Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada.基于人群的 BRCA1 和 BRCA2 检测在加拿大的经济评估。
JAMA Netw Open. 2024 Sep 3;7(9):e2432725. doi: 10.1001/jamanetworkopen.2024.32725.
5
Cascade genetic testing: an underutilized pathway to equitable cancer care?级联基因检测：实现公平癌症护理的未充分利用途径？
Fam Cancer. 2024 Jun;23(2):141-145. doi: 10.1007/s10689-024-00367-2. Epub 2024 May 15.
6
Implementation Mapping for Managing Patients at High Risk for Hereditary Cancer.遗传性癌症高危患者管理的实施映射。
Am J Prev Med. 2024 Mar;66(3):503-515. doi: 10.1016/j.amepre.2023.09.032. Epub 2023 Oct 6.
7
Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention.针对乳腺癌风险升高的女性进行遗传咨询和检测：Know Your Risk 干预措施的随机对照试验方案。
Contemp Clin Trials. 2023 Oct;133:107323. doi: 10.1016/j.cct.2023.107323. Epub 2023 Sep 1.
8
Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon's practice in a large US Academic Center.对乳腺癌患者进行主流的基因检测：来自美国一家大型学术中心一位外科医生的实践经验。
Fam Cancer. 2023 Oct;22(4):467-474. doi: 10.1007/s10689-023-00342-3. Epub 2023 Jun 24.
9
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.意大利胰腺癌患者非选择队列中51个癌症易感基因种系致病变异的临床意义
Cancers (Basel). 2022 Sep 13;14(18):4447. doi: 10.3390/cancers14184447.
10
Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.促进乳腺癌风险遗传咨询的文化敏感干预的初步研究。
BMC Health Serv Res. 2022 Jun 25;22(1):826. doi: 10.1186/s12913-022-08193-x.